HomeDXCM • NASDAQ
add
DexCom Inc
Previous close
$61.18
Day range
$59.83 - $60.95
Year range
$56.45 - $93.24
Market cap
23.34B USD
Avg Volume
6.29M
P/E ratio
34.15
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.21B | 21.64% |
Operating expense | 488.90M | 10.66% |
Net income | 283.80M | 110.85% |
Net profit margin | 23.47 | 73.34% |
Earnings per share | 0.61 | 35.56% |
EBITDA | 306.10M | 47.66% |
Effective tax rate | 19.44% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.32B | 33.29% |
Total assets | 7.50B | 18.04% |
Total liabilities | 4.77B | 9.12% |
Total equity | 2.73B | — |
Shares outstanding | 390.02M | — |
Price to book | 8.75 | — |
Return on assets | 8.18% | — |
Return on capital | 11.60% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 283.80M | 110.85% |
Cash from operations | 659.90M | 230.78% |
Cash from investing | 192.80M | -8.32% |
Cash from financing | -175.00M | 76.24% |
Net change in cash | 676.60M | 312.70% |
Free cash flow | 406.62M | 740.79% |
About
Dexcom, Inc. is an American healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland. Wikipedia
Founded
1999
Headquarters
Website
Employees
10,250
